EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology

Shirin Jannati, Adiba Patel iD, Rajashree Patnaik, Yajnavalka Banerjee iD

International Journal of Molecular Sciences · 09.06.2025 · 26 (12) · 5521

DOI: 10.3390/ijms26125521 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.06.2025. Verfasst von Shirin Jannati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai P.O. B…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms, Cyclopentane Monoterpenes, Aldehydes. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oleocanthal (OC), a secoiridoid phenolic compound exclusive to extra virgin olive oil (EVOO), has emerged as a promising nutraceutical with multifaceted anti-cancer properties. Despite its well-characterized anti-inflammatory and antioxidant effects, the mechanistic breadth and translational potential of OC in oncology remain underexplored and fragmented across the literature. This comprehensive review synthesizes and critically analyzes recent advances in the molecular, pharmacological, and translational landscape of OC’s anti-cancer activities, providing an integrative framework to bridge preclinical evidence with future clinical application. We delineate the pleiotropic mechanisms by which OC modulates cancer hallmarks, including lysosomal membrane permeabilization (LMP)-mediated apoptosis, the inhibition of key oncogenic signaling pathways (c-MET/STAT3, PAR-2/TNF-α, COX-2/mPGES-1), the suppression of epithelial-to-mesenchymal transition (EMT), angiogenesis, and metabolic reprogramming. Furthermore, this review uniquely highlights the emerging role of OC in modulating drug resistance mechanisms by downregulating efflux transporters and sensitizing tumors to chemotherapy, targeted therapies, and immunotherapies. We also examine OC’s bidirectional interaction with gut microbiota, underscoring its systemic immunometabolic effects. A major unmet need addressed by this review is the lack of consolidated knowledge regarding OC’s pharmacokinetic limitations and drug–drug interaction potential in the context of polypharmacy in oncology. We provide an in-depth analysis of OC’s poor bioavailability, extensive first-pass metabolism, and pharmacogenomic interactions, and systematically compile preclinical evidence on advanced delivery platforms—including nanocarriers, microneedle systems, and peptide–drug conjugates—designed to overcome these barriers. By critically evaluating the mechanistic, pharmacological, and translational dimensions of OC, this review advances the field beyond isolated mechanistic studies and offers a strategic blueprint for its integration into precision oncology. It also identifies key research gaps and outlines the future directions necessary to transition OC from a nutraceutical of dietary interest to a viable adjunctive therapeutic agent in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsCyclopentane MonoterpenesAldehydesHumansPrecision MedicineAnimalsDrug Delivery SystemsPhenols

Stichwörter der Autor:innen

Mediterranean dietcancer metabolismgut microbiomelysosomal membrane permeabilizationnanoparticle drug deliveryoleocanthalpolyphenolsprecision oncology

Substanzen

Antineoplastic AgentsoleocanthalCyclopentane MonoterpenesAldehydesPhenols

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai P.O. Box 505055, United Arab Emirates.
  • Birla Institute of Technology & Science, Pilani-Dubai Campus (BITS Pilani, Dubai Campus), Dubai International Academic City, Dubai P.O. Box 345055, United Arab Emirates.

ORCID-Profile: Adiba Patel, Yajnavalka Banerjee

Zitieren

APA

Jannati, S., Patel, A., Patnaik, R., & Banerjee, Y. (2025). Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. International Journal of Molecular Sciences, 26(12), 5521. https://doi.org/10.3390/ijms26125521

Vancouver

Jannati S, Patel A, Patnaik R, Banerjee Y. Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. International Journal of Molecular Sciences. 2025;26(12):5521. doi:10.3390/ijms26125521

BibTeX
@article{Jannati2025,
  author = {Jannati, Shirin and Patel, Adiba and Patnaik, Rajashree and Banerjee, Yajnavalka},
  title = {Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {12},
  pages = {5521},
  doi = {10.3390/ijms26125521}
}
Kostenlos starten →